My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

67.43 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

32 33 Next >

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗

December 19, 2025

DexCom (DXCM) combines strong growth fundamentals with a promising technical breakout setup, offering a potential entry point for investors.

Via Chartmill

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

December 18, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification

December 16, 2025

December 16, 2025 – The "buying the dip" investment strategy, which involves purchasing an asset after its price has declined with the anticipation of a subsequent recovery, has seen significant...

Via MarketMinute

Topics Artificial Intelligence Economy

Navigating Nuance: Tech Innovation, Healthcare Revival, and Energy's Evolving Landscape Shape Late 2025 Markets

December 11, 2025

As December 2025 unfolds, global financial markets are characterized by a delicate balance of cautious optimism and persistent uncertainty. A "Santa Claus rally" sentiment prevails, fueled by...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

DexCom Inc (NASDAQ:DXCM) Emerges as a Top Affordable Growth Stock ↗

December 05, 2025

DexCom (DXCM) exemplifies the GARP strategy, offering strong revenue & earnings growth, high profitability, and a reasonable valuation within its high-growth industry.

Via Chartmill

3 Mid-Cap Stocks to Research Further

December 03, 2025

Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses...

Via StockStory

Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies.

Via StockStory

Topics Economy Government

2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon ↗

November 23, 2025

If you're investing for the next 30 years, don't overlook these top stocks.

Via The Motley Fool

Topics Intellectual Property

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy Government World Trade

Top 2 Healthcare Stocks Every New Investor Should Know ↗

November 21, 2025

These healthcare stocks have long-term and profitable growth runways.

Via The Motley Fool

Uncover the latest developments among S&P500 stocks in today's session. ↗

November 18, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

3 Reasons We’re Fans of DexCom (DXCM)

November 17, 2025

What a brutal six months it’s been for DexCom. The stock has dropped 32.6% and now trades at $58.63, rattling many shareholders. This may have investors wondering how to approach the situation.

Via StockStory

2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 Facing Headwinds

November 16, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

November 12, 2025

Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers.

Via StockStory

Topics Artificial Intelligence

DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price? ↗

November 12, 2025

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Via The Motley Fool

Topics Economy

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Exploring the top movers within the S&P500 index during today's session. ↗

November 11, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Wall Street Pauses, Silver Reclaims $50 With Shutdown End In Sight: What's Moving Markets Tuesday? ↗

November 11, 2025

U.S. equities took a breather on Tuesday, stabilizing after Monday's sharp rally as investors awaited a House vote on the temporary spending bill expected to end the record-long government shutdown...

Via Benzinga

What's going on in today's session: S&P500 movers ↗

November 11, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street ↗

November 11, 2025

Shares are near their lowest levels in five years.

Via The Motley Fool

Topics Lawsuit

DexCom Inc (NASDAQ:DXCM) Embodies the Affordable Growth Investment Method ↗

November 11, 2025

DexCom (DXCM) offers affordable growth with strong expansion, solid profitability, and a reasonable valuation in the diabetes care market.

Via Chartmill

2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds

November 10, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Why TAL Education, Shake Shack And DexCom Just Appeared On Value Investors' Radars ↗

November 08, 2025

A trio of stocks made an impressive leap in their Benzinga Edge value scores this week, with one standout making a 138% jump.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

November 07, 2025

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Friday's session: top gainers and losers in the S&P500 index ↗

November 07, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Gapping S&P500 stocks in Friday's session ↗

November 07, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Via Chartmill

From Dividends to Growth: Why These 3 Stocks Stand Out in 2025 ↗

November 06, 2025

Via MarketBeat

The 5 Most Interesting Analyst Questions From DexCom’s Q3 Earnings Call

November 06, 2025

DexCom's third quarter was met with a negative market reaction despite outpacing Wall Street’s revenue and adjusted EPS expectations. Management attributed quarterly growth to increased continuous...

Via StockStory

Topics Earnings

3 Nasdaq 100 Stocks Worth Investigating

November 05, 2025

The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.